Interactive Investor
>>

Redx Pharma (LSE:REDX) Share Price

REDX

Redx Pharma

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others.Redx Pharma PLC is principally engaged in drug discovery, pre-clinical development and licensing. It has an established portfolio of proprietary drug programs that it is developing alone and in partnership with pharmaceutical companies.

LSE:REDX

GB00BSNB6S51

GBX

Loading...

Loading Comparison

Latest REDX News

REDX Regulatory News